Literature DB >> 10896321

Selectivity analysis of 5-(arylthio)-2,4-diaminoquinazolines as inhibitors of Candida albicans dihydrofolate reductase by molecular dynamics simulations.

V M Gokhale1, V M Kulkarni.   

Abstract

A series of 5-(arylthio)-2,4-diaminoquinazolines are known as selective inhibitors of dihydrofolate reductase (DHFR) from Candida albicans. We have performed docking and molecular dynamics simulations of these inhibitors with C. albicans and human DHFR to understand the basis for selectivity of these agents. Study was performed on a selected set of 10 compounds with variation in structure and activity. Molecular dynamics simulations were performed at 300 K for 45 ps with equilibration for 10 ps. Trajectory data was analyzed on the basis of hydrogen bond interactions, energy of binding and conformational energy difference. The results indicate that hydrogen bonds formed between the compound and the active site residues are responsible for inhibition and higher potency. The selectivity index, i.e the ratio of I50 against human DHFR to I50 against fungal DHFR, is mainly determined by the conformation adapted by the compounds within the active site of two enzymes. Since the human DHFR active site is rigid, the compound is trapped in a higher energy conformation. This energy difference between the two conformations deltaE mainly governs the selectivity against fungal DHFR. The information generated from this analysis of potency and selectivity should be useful for further work in the area of antifungal research.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10896321     DOI: 10.1023/a:1008189724803

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  18 in total

1.  Molecular modeling and site-directed mutagenesis studies of a phorbol ester-binding site in protein kinase C.

Authors:  S Wang; M G Kazanietz; P M Blumberg; V E Marquez; G W Milne
Journal:  J Med Chem       Date:  1996-06-21       Impact factor: 7.446

2.  Dihydrofolate reductase: multiple conformations and alternative modes of substrate binding.

Authors:  B Birdsall; J Feeney; S J Tendler; S J Hammond; G C Roberts
Journal:  Biochemistry       Date:  1989-03-07       Impact factor: 3.162

3.  Structure based prediction of binding affinity of human immunodeficiency virus-1 protease inhibitors.

Authors:  S S Kulkarni; V M Kulkarni
Journal:  J Chem Inf Comput Sci       Date:  1999 Nov-Dec

4.  Calculation of the total electrostatic energy of a macromolecular system: solvation energies, binding energies, and conformational analysis.

Authors:  M K Gilson; B Honig
Journal:  Proteins       Date:  1988

5.  Crystal structure of avian dihydrofolate reductase containing phenyltriazine and NADPH.

Authors:  K W Volz; D A Matthews; R A Alden; S T Freer; C Hansch; B T Kaufman; J Kraut
Journal:  J Biol Chem       Date:  1982-03-10       Impact factor: 5.157

6.  Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411.

Authors:  P Furet; G Caravatti; N Lydon; J P Priestle; J M Sowadski; U Trinks; P Traxler
Journal:  J Comput Aided Mol Des       Date:  1995-12       Impact factor: 3.686

7.  Understanding the binding of 5-substituted 2'-deoxyuridine substrates to thymidine kinase of herpes simplex virus type-1.

Authors:  H De Winter; P Herdewijn
Journal:  J Med Chem       Date:  1996-11-22       Impact factor: 7.446

8.  Molecular dynamics simulations of the structure of aldose reductase complexed with the inhibitor tolrestat.

Authors:  G Rastelli; L Costantino
Journal:  Bioorg Med Chem Lett       Date:  1998-03-17       Impact factor: 2.823

9.  Docking analysis of a series of benzylamino acetylcholinesterase inhibitors with a phthalimide, benzoyl, or indanone moiety.

Authors:  Y Yamamoto; Y Ishihara; I D Kuntz
Journal:  J Med Chem       Date:  1994-09-16       Impact factor: 7.446

10.  Selective inhibitors of Candida albicans dihydrofolate reductase: activity and selectivity of 5-(arylthio)-2,4-diaminoquinazolines.

Authors:  J H Chan; J S Hong; L F Kuyper; D P Baccanari; S S Joyner; R L Tansik; C M Boytos; S K Rudolph
Journal:  J Med Chem       Date:  1995-09-01       Impact factor: 7.446

View more
  2 in total

1.  3D-QSAR and molecular modeling of HIV-1 integrase inhibitors.

Authors:  Mahindra T Makhija; Vithal M Kulkarni
Journal:  J Comput Aided Mol Des       Date:  2002-03       Impact factor: 3.686

Review 2.  Chemical space of Escherichia coli dihydrofolate reductase inhibitors: New approaches for discovering novel drugs for old bugs.

Authors:  Bharath Srinivasan; Sam Tonddast-Navaei; Ambrish Roy; Hongyi Zhou; Jeffrey Skolnick
Journal:  Med Res Rev       Date:  2018-09-07       Impact factor: 12.944

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.